MiR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300

Experimental Cell Research

Volumn 319, Issue 3, 2013, Pages 173-184

  Duan, Yaqian ^a   Zhou, Bo ^a   Su, Hong ^a   Liu, Yuhang ^a   Du, Chao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cardiomyocyte hypertrophy; High glucose; Histone acetyl transferase; MiRNAs

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; GLUCOSE; MICRORNA; MICRORNA 150; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOCYTE HYPERTROPHY; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; EVENT RELATED POTENTIAL; HEART MUSCLE CELL; HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

RATTUS;

EID: 84872409477     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.11.015     Document Type: Article

References (37)

1. Voulgari C., Papadogiannis D., Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc. Health Risk. Manage. 2010, 6:883-903.
2. Chien K.R., Zhu H., Knowlton K.U., Miller-Hance W., van-Bilsen M., O'Brien T.X., Evans S.M. Transcriptional regulation during cardiac growth and development. Annu. Rev. Physiol. 1993, 55:77-95.
3. Feng B., Chen S., Chiu J., George B., Chakrabarti S. Regulation of cardiomyocyte hypertrophyin diabetes at the transcriptional level. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E1119-1126.
4. Morimoto T., Sunagawa Y., Fujita M., Hasegawa K. Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin. Circ. J. 2010, 74:1059-1066.
5. Wei J.Q., Shehadeh L.A., Mitrani J.M., Pessanha M., Slepak T.I., Webster K.A., Bishopric N.H. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 2008, 118:934-946.
6. Chiu J., Farhangkhoee H., Xu B.Y., Chen S., George B., Chakrabarti S. PARP mediates structural alterations in diabetic cardiomyopathy. J. Mol. Cell Cardiol. 2008, 45:385-393.
7. Chan H.M., La Thangue N.B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 2001, 114:2363-2373.
8. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
9. Miyamoto S., Kawamura T., Morimoto T., Ono K., Wada H., Kawase Y., Matsumori A., Nishio R., Kita T., Hasegawa K. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation 2006, 113:679-690.
10. Morimoto T., Sunagawa Y., Kawamura T., Takaya T., Wada H., Nagasawa A., Komeda M., Fujita M., Shimatsu A., Kita T., Hasegawa K. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J. Clin. Invest. 2008, 118:868-878.
11. Chen L.F., Greene W.C. Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation. J. Mol. Med. 2003, 81:549-557.
12. Chen S., Khan Z.A., Cukiernik M., Chakrabarti S. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E1089-E1097.
13. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans hetero chronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
14. Pasquinelli A.E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 2012, 13:271-282.
15. Feng B., Chen S., George B., Feng Q., Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab. Res. Rev. 2010, 26:40-49.
16. Shen E., Diao X., Wang X., Chen R., Hu B. MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy. Am. J. Pathol. 2011, 179:639-650.
17. Sayed D., Hong C., Chen I.Y., Lypowy J., Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 2007, 100:416-424.
18. Tatsuguchi M., Seok H.Y., Callis T.E., Thomson J.M., Chen J.F., Newman M., Rojas M., Hammond S.M., Wang D.Z. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J. Mol. Cell Cardiol. 2007, 42:1137-1141.
19. Rooij van, Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 2006, 103:18255-18260.
20. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
21. Lagos D., Pollara G., Henderson S., Gratrix F., Fabani M., Milne R.S., Gotch F., Boshoff C. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell Biol. 2010, 12:513-519.
22. Feng B., Chen S., McArthur K., Wu Y., Sen S., Ding Q., Feldman R.D., Chakrabarti S. miR-146a-mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 2011, 60:2975-2984.
23. Gladka M.M., da Costa Martins P.A., De Windt L.J. Small changes can make a big difference-microRNA regulation of cardiac hypertrophy. J. Mol. Cell. Cardiol. 2012, 52:74-82.
24. Cheng Y., Ji R., Yue J., Yang J., Liu X., Chen H., Dean D.B., Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?. Am. J. Pathol. 2007, 170:1831-1840.
25. Srivastava S.K., Bhardwaj A., Singh S., Arora S., Wang B., Grizzle W.E., Singh A.P. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 2011, 32:1832-1839.
26. Xiao C., Calado D.P., Galler G., Thai T.H., Patterson H.C., Wang J., Rajewsky N., Bender T.P., Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159.
27. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., Sun F., Lu J., Yin Y., Cai X., Sun Q., Wang K., Ba Y., Wang Q., Wang D., Yang J., Liu P., Xu T., Yan Q., Zhang J., Zen K., Zhang C.Y. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 2010, 39:133-144.
28. McKinsey T.A., Olson E.N. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J. Clin. Invest. 2005, 115:538-546.
29. Chen K., Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 2007, 8:93-103.
30. Janga S.C., Vallabhaneni S. MicroRNAs as post-transcriptional machines and their interplay with cellular networks. Adv. Exp. Med. Biol. 2011, 722:59-74.
31. Carè A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., Bang M.L., Segnalini P., Gu Y., Dalton N.D., Elia L., Latronico M.V., H.M.Høydal M., Autore C., Russo M.A., Dorn G.W., Ellingsen O., Ruiz-Lozano P., Peterson K.L., Croce C.M., Peschle C., Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 2007, 13:613-618.
32. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
33. Nagareddy P.R., Soliman H., Lin G., Rajput P.S., Kumar U., McNeill J.H., MacLeod K.M. Selective inhibition of protein kinase C beta2 attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats. Diabetes 2009, 58:2355-2364.
34. Xia Z., Kuo K.H., Nagareddy P.R., Wang F., Guo Z., Guo T., Jiang J., McNeill J.H. N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats. Cardiovasc. Res. 2007, 73:770-782.
35. Chiang C.W., Huang Y., Leong K.W., Chen L.C., Chen H.C., Chen S.J., Chou C.K. PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells. J. Biomed. Sci. 2010, 6:17-35.
36. Sonkoly E., Wei T., Pavez Loriè E., Suzuki H., Kato M., Törmä H., Ståhle M., Pivarcsi A. Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes. J. Invest. Dermatol. 2010, 130:124-134.
37. Sutcliffe E.L., Bunting K.L., He Y.Q., Li J., Phetsouphanh C., Seddiki N., Zafar A., Hindmarsh E.J., Parish C.R., Kelleher A.D., McInnes R.L., Taya T., Milburn P.J., Rao S. Chromatin-associated protein kinase C-θ regulates an inducible gene expression program and microRNAs in human T lymphocytes. Mol. Cell 2011, 41:704-719.